AVITA Medical (ASX:AVH) Tariff Resilience Score: 5/10 (As of Jun. 30, 2026)


ASX:AVH AVITA Medical Inc ASX:AVH
58 GF Score
Price A$1.20
GF Value A$2.92
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is AVITA Medical Tariff Resilience Score?

AVITA Medical ASX:AVH +4.35% 58 Tariff Resilience Score is 5 as of Jun. 30, 2026. GuruFocus rates ASX:AVH with a GF Score™ of 58/100 and a GF Value™ of A$2.92 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 838 Medical Devices & Instruments companies, AVITA Medical ranks better than 79.12% on this metric.

AVITA Medical has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

AVITA Medical has AVITA Medical faces moderate tariff risks due to its reliance on international suppliers for medical devices. While it has some pricing power, its limited scale and alternative suppliers increase vulnerability to tariff changes.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes AVITA Medical might have Average Resilient.

AVITA Medical  (ASX:AVH) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

AVITA Medical Tariff Resilience Score Related Terms

ASX:AVH vs MXCT, HYPR, ZOMDF: Tariff Resilience Score Comparison

For the Medical Devices subindustry, AVITA Medical's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AVITA Medical Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AVITA Medical's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where AVITA Medical's Tariff Resilience Score falls into.


ASX:AVH
58GF Score
AVITA Medical Inc ASX:AVH
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
AVITA Medical (ASX:AVH) has a Tariff Resilience Score of 5 as of Jun. 30, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, AVITA Medical ranks #175 out of 838 companies in the Medical Devices & Instruments industry, placing it in the top 20.9%.
Is AVITA Medical's Tariff Resilience Score too high?
AVITA Medical's current Tariff Resilience Score is 5. Based on the distribution chart, AVITA Medical ranks #175 out of 838 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, AVITA Medical has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does AVITA Medical's Tariff Resilience Score compare to MXCT and HYPR?
According to the Medical Devices & Instruments industry distribution chart, AVITA Medical ranks #175 out of 838 companies for Tariff Resilience Score. This places AVITA Medical in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. AVITA Medical's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AVITA Medical stock overvalued right now?
Based on GuruFocus' analysis, AVITA Medical (ASX:AVH) is currently considered Possible Value Trap. The stock's GF Value™ is A$2.92, compared to a current price of A$1.20 — trading 58.9% below its estimated fair value. The current Tariff Resilience Score is 5. AVITA Medical's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For AVITA Medical (ASX:AVH), the current Tariff Resilience Score is 5 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AVITA Medical (ASX:AVH) Overvalued in 2026?

Based on GuruFocus' analysis, AVITA Medical stock appears to be undervalued. The current stock price of A$1.20 is trading 58.9% below its estimated GF Value™ of A$2.92. GuruFocus considers AVITA Medical to be Possible Value Trap.

Key valuation signals for ASX:AVH:

  • Tariff Resilience Score: 5
  • GF Value™: A$2.92 vs. price of A$1.20 (58.9% below fair value)
  • GF Score™: 58/100 with 6 warning signs

No single metric tells the full story. See the ASX:AVH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AVITA Medical Business Description

Address 28159 Avenue Stanford, Suite 220, Valencia, Santa Clarita, CA, USA, 91355
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
58GF Score

Get the complete analysis for ASX:AVH

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.20
Price
A$2.92
GF Value